Changes in ER, PR, HER2, and Their Association With Disease Outcome in Invasive Breast Carcinoma (IBC) Patients Post-Neo Adjuvant Chemotherapy (NAC) and Surgery
Background: Estrogen-receptor (ER), progesterone-receptor (PR), and human epidermal growth factor-2 (HER2) are performed on pre-neoadjuvant chemotherapy (NAC) biopsies of invasive breast carcinoma (IBC). However, they are not done routinely on post-NAC IBC with residual tumor. Objectives: This study...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Breast Cancer: Basic and Clinical Research |
| Online Access: | https://doi.org/10.1177/11782234251342463 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850231846737018880 |
|---|---|
| author | Monisha C Ravishankar Pampa Ch Toi Biswaji Dubashi Kadambari Dharanipragada |
| author_facet | Monisha C Ravishankar Pampa Ch Toi Biswaji Dubashi Kadambari Dharanipragada |
| author_sort | Monisha C Ravishankar |
| collection | DOAJ |
| description | Background: Estrogen-receptor (ER), progesterone-receptor (PR), and human epidermal growth factor-2 (HER2) are performed on pre-neoadjuvant chemotherapy (NAC) biopsies of invasive breast carcinoma (IBC). However, they are not done routinely on post-NAC IBC with residual tumor. Objectives: This study helps in understanding the effect of alteration in expression of ER, PR, and HER2 in pre and post NAC IBC with residual tumors in terms of disease outcome, such as disease-free survival (DFS) and overall survival (OS). Design: This was a Cohort study (Prospective and Retrospective Cohort). Methods: All newly diagnosed cases of IBC who had undergone surgery after NAC with pre-NAC biopsies available with residual tumors in the breast, from January 2017 to January 2020 were enrolled in the study (n = 174) and were followed up till July 2022. Results: There were 174 cases included in this study. Of the 174 cases, 77 (44%) ER+ cases turned −ve, 10 ER +ve cases remained +ve and 87(50%) cases which were ER−ve remained the same. 48(27%) of PR +ve cases turned −ve, 10 PR +ve cases remained +ve and 116 (67%) cases remained −ve. 64(36%) of HER2 +ve cases turned −ve, 4 (2%) of HER2 +ve cases remained +ve; whereas 103(59%) cases remained −ve. The cases with changes in ER and HER2 status from positive to negative showed a longer DFS and OS which was statistically significant. Conclusion: There is a change in the HR and HER2 status in cases of IBC with residual tumor post NAC and patients with changes in the receptor status post-NAC have a better OS and DFS than those whose receptor status do not show a change. |
| format | Article |
| id | doaj-art-d3f122e7bec04b9480c809254b4e9ce4 |
| institution | OA Journals |
| issn | 1178-2234 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Breast Cancer: Basic and Clinical Research |
| spelling | doaj-art-d3f122e7bec04b9480c809254b4e9ce42025-08-20T02:03:24ZengSAGE PublishingBreast Cancer: Basic and Clinical Research1178-22342025-06-011910.1177/11782234251342463Changes in ER, PR, HER2, and Their Association With Disease Outcome in Invasive Breast Carcinoma (IBC) Patients Post-Neo Adjuvant Chemotherapy (NAC) and SurgeryMonisha C Ravishankar0Pampa Ch Toi1Biswaji Dubashi2Kadambari Dharanipragada3Department of Pathology, JIPMER, Puducherry, IndiaDepartment of Pathology, JIPMER, Puducherry, IndiaDepartment of Medical Oncology, JIPMER, Puducherry, IndiaDepartment of Surgery, JIPMER, Puducherry, IndiaBackground: Estrogen-receptor (ER), progesterone-receptor (PR), and human epidermal growth factor-2 (HER2) are performed on pre-neoadjuvant chemotherapy (NAC) biopsies of invasive breast carcinoma (IBC). However, they are not done routinely on post-NAC IBC with residual tumor. Objectives: This study helps in understanding the effect of alteration in expression of ER, PR, and HER2 in pre and post NAC IBC with residual tumors in terms of disease outcome, such as disease-free survival (DFS) and overall survival (OS). Design: This was a Cohort study (Prospective and Retrospective Cohort). Methods: All newly diagnosed cases of IBC who had undergone surgery after NAC with pre-NAC biopsies available with residual tumors in the breast, from January 2017 to January 2020 were enrolled in the study (n = 174) and were followed up till July 2022. Results: There were 174 cases included in this study. Of the 174 cases, 77 (44%) ER+ cases turned −ve, 10 ER +ve cases remained +ve and 87(50%) cases which were ER−ve remained the same. 48(27%) of PR +ve cases turned −ve, 10 PR +ve cases remained +ve and 116 (67%) cases remained −ve. 64(36%) of HER2 +ve cases turned −ve, 4 (2%) of HER2 +ve cases remained +ve; whereas 103(59%) cases remained −ve. The cases with changes in ER and HER2 status from positive to negative showed a longer DFS and OS which was statistically significant. Conclusion: There is a change in the HR and HER2 status in cases of IBC with residual tumor post NAC and patients with changes in the receptor status post-NAC have a better OS and DFS than those whose receptor status do not show a change.https://doi.org/10.1177/11782234251342463 |
| spellingShingle | Monisha C Ravishankar Pampa Ch Toi Biswaji Dubashi Kadambari Dharanipragada Changes in ER, PR, HER2, and Their Association With Disease Outcome in Invasive Breast Carcinoma (IBC) Patients Post-Neo Adjuvant Chemotherapy (NAC) and Surgery Breast Cancer: Basic and Clinical Research |
| title | Changes in ER, PR, HER2, and Their Association With Disease Outcome in Invasive Breast Carcinoma (IBC) Patients Post-Neo Adjuvant Chemotherapy (NAC) and Surgery |
| title_full | Changes in ER, PR, HER2, and Their Association With Disease Outcome in Invasive Breast Carcinoma (IBC) Patients Post-Neo Adjuvant Chemotherapy (NAC) and Surgery |
| title_fullStr | Changes in ER, PR, HER2, and Their Association With Disease Outcome in Invasive Breast Carcinoma (IBC) Patients Post-Neo Adjuvant Chemotherapy (NAC) and Surgery |
| title_full_unstemmed | Changes in ER, PR, HER2, and Their Association With Disease Outcome in Invasive Breast Carcinoma (IBC) Patients Post-Neo Adjuvant Chemotherapy (NAC) and Surgery |
| title_short | Changes in ER, PR, HER2, and Their Association With Disease Outcome in Invasive Breast Carcinoma (IBC) Patients Post-Neo Adjuvant Chemotherapy (NAC) and Surgery |
| title_sort | changes in er pr her2 and their association with disease outcome in invasive breast carcinoma ibc patients post neo adjuvant chemotherapy nac and surgery |
| url | https://doi.org/10.1177/11782234251342463 |
| work_keys_str_mv | AT monishacravishankar changesinerprher2andtheirassociationwithdiseaseoutcomeininvasivebreastcarcinomaibcpatientspostneoadjuvantchemotherapynacandsurgery AT pampachtoi changesinerprher2andtheirassociationwithdiseaseoutcomeininvasivebreastcarcinomaibcpatientspostneoadjuvantchemotherapynacandsurgery AT biswajidubashi changesinerprher2andtheirassociationwithdiseaseoutcomeininvasivebreastcarcinomaibcpatientspostneoadjuvantchemotherapynacandsurgery AT kadambaridharanipragada changesinerprher2andtheirassociationwithdiseaseoutcomeininvasivebreastcarcinomaibcpatientspostneoadjuvantchemotherapynacandsurgery |